Travere Therapeutics Inc (TVTX) returns
Travere Therapeutics returns over 10 years
$1,000 invested in Travere Therapeutics ten years ago was worth $2,651 at the close on October 30, 2026, with dividends reinvested: an average return of 10.2% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -14.4% | — | $855.81 | -0.9% |
| 3 months | -12.0% | — | $879.71 | +2.1% |
| Year to date | +31.9% | — | $1,319 | +11.7% |
| 1 year | +69.9% | — | $1,699 | +12.4% |
| 3 years | +645.4% | +95.3% | $7,454 | +88.5% |
| 5 years | +74.9% | +11.8% | $1,749 | +76.0% |
| 10 years | +165.1% | +10.2% | $2,651 | +316.6% |
Travere Therapeutics return by calendar year
| Year | TVTX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +31.9% | +11.7% | +20.2% |
| 2025 | +119.3% | +17.7% | +101.6% |
| 2024 | +93.8% | +24.9% | +68.9% |
| 2023 | -57.3% | +26.2% | -83.4% |
| 2022 | -32.2% | -18.2% | -14.1% |
| 2021 | +13.9% | +28.7% | -14.9% |
| 2020 | +91.9% | +18.4% | +73.6% |
| 2019 | -37.3% | +31.2% | -68.5% |
| 2018 | +7.4% | -4.6% | +12.0% |
| 2017 | +11.3% | +21.7% | -10.4% |
| 2016 | -1.9% | +12.0% | -13.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: TVTX financials
No forecast, no recommendation. This page describes Travere Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.